NEXI

Q: What is the price of NexImmune (NEXI) today?

The price of NexImmune (NEXI) today is $ 0.000100, with return of -99.96% compared to the last year. The price of NexImmune (NEXI) started the year trading around $ 0.13 and today it is at $ 0.000100. Follow the real-time price chart, the historical price of NexImmune (NEXI) and international markets.

Q: When does NexImmune (NEXI) pay dividends?

NexImmune (NEXI) did not distribute dividends in the last year.

Q: Is NexImmune (NEXI) worth it?

Currently, NexImmune (NEXI) is priced at $ 0.000100, with a P/E of 0.00%, representing a deviation of -1,069% from its historical average P/E. In the last year, the stock showed a variation of -99.96 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -99.96%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy NexImmune (NEXI) stock?

Investing in stocks of NexImmune (NEXI) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of NexImmune (NEXI) yield today?

The yield of NexImmune (NEXI) was 0.00% in the last month, -99.96% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of NexImmune (NEXI) today, the total investment would be $ 0.01, based on the current price of $ 0.000100.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.000004In 5 years: $ 0.01In 10 years: $ 0.01It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

NexImmune Inc.

Price

$ 0.000100

return (12m)

-99.96%

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

price NEXI

NEXI

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of NEXI

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

-50.00%

1 year

-99.96%

2 years

-100.00%

5 years

0.00%

10 years

0.00%

Fundamentals NEXI

review the fundamentals of NexImmune shares

P/E

0.00

Sector: -3.62 Industry: -3.62

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-8.59%

Sector: - Industry: -

Fundamentals NEXI

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	19.71	0.00	0.00%	2.47%	$ 495.09 B	27.26%
PFE	14.63	1.54	10.56%	8.46%	$ 143.80 B	15.65%
ABBV	168.68	-154.98	-91.88%	2.88%	$ 402.80 B	4.00%
NVO	14.23	8.21	57.70%	3.42%	$ 219.31 B	32.78%
MRK	13.76	0.00	0.00%	3.09%	$ 261.87 B	29.63%
AZN	30.60	6.26	20.45%	1.69%	$ 287.62 B	16.17%
BMY	16.59	5.39	32.47%	5.04%	$ 100.17 B	12.57%
GILD	19.29	7.29	37.80%	2.50%	$ 156.42 B	27.88%
ZTS	21.42	10.52	49.11%	1.51%	$ 56.78 B	28.21%
HALO	14.03	16.58	118.17%	0.00%	$ 8.35 B	47.91%
REGN	17.72	2.62	14.79%	0.34%	$ 81.14 B	32.13%
AMGN	26.53	19.32	72.82%	2.72%	$ 185.86 B	19.47%
VRTX	30.20	6.41	21.22%	0.00%	$ 111.00 B	31.35%
MCK	27.09	-189.03	-697.75%	0.33%	$ 109.26 B	1.04%
ADMA	21.89	10.63	48.57%	0.00%	$ 4.58 B	42.87%
CAH	31.67	-18.50	-58.40%	0.96%	$ 50.52 B	0.68%
BIIB	16.64	1.47	8.83%	0.00%	$ 26.77 B	15.98%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

NEXI Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY NexImmune

NexImmune Inc.

Average user rating I10

4.0 (0 people)

United States

14 years

Founded: 2011

2021

Time since IPO - 4 years

44

Employees

The Company NexImmune Inc. (United States), is listed on Nasdaq with a market cap of $ 100.00 , having an equity of $ 920.00 Thousand.

With a total of 44 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -20.62 Millions.

As for its main indicators, the Company has a P/E ratio of 0.00, a P/BV ratio of 0.00 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker NEXI.

Market cap

$ 100.00

Equity

$ 920.00 Thousand

US$ 920,000.00

Assets

$ 5.86 Millions

US$ 5,860,000.00

Total Shares Outstanding

1.00 Million

1,000,000

Average Daily Trading Volume

$ 580.86

US$ 580.86

Sector

Health Care

Industry

Biotechnology

NEXI

NEXI revenue and profits

Financial Results NEXI

DRAG THE FRAME TO SEE MORE DATA

NEXI cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 814.18 34,74% (12M)

P/E

27.09

0.33%

ROE

-697.75%

P/BV

-189.03

CAH - Cardinal Health

$ 199.19 64,88% (12M)

P/E

31.67

0.96%

ROE

-58.40%

P/BV

-18.50

JNJ - Johnson & Johnson

$ 202.48 40,69% (12M)

P/E

19.71

2.47%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 100.89 1,87% (12M)

P/E

13.76

3.09%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.70 7,11% (12M)

P/E

14.63

8.46%

ROE

10.56%

P/BV

1.54

ABBV - AbbVie

$ 228.71 35,39% (12M)

P/E

168.68

2.88%

ROE

-91.88%

P/BV

-154.98

AZN - AstraZeneca

$ 90.03 36,16% (12M)

P/E

30.60

1.69%

ROE

20.45%

P/BV

6.26

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 814.18 34,74% (12 M)

P/L

27.09

0.33%

ROE

-697.75%

P/VP

-189.03

CAH - Cardinal Health

$ 199.19 64,88% (12 M)

P/L

31.67

0.96%

ROE

-58.40%

P/VP

-18.50

JNJ - Johnson & Johnson

$ 202.48 40,69% (12 M)

P/L

19.71

2.47%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 100.89 1,87% (12 M)

P/L

13.76

3.09%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.70 7,11% (12 M)

P/L

14.63

8.46%

ROE

10.56%

P/VP

1.54

ABBV - AbbVie

$ 228.71 35,39% (12 M)

P/L

168.68

2.88%

ROE

-91.88%

P/VP

-154.98

AZN - AstraZeneca

$ 90.03 36,16% (12 M)

P/L

30.60

1.69%

ROE

20.45%

P/VP

6.26

Frequently Asked Questions

What is the price of NexImmune (NEXI) today?

The price of NexImmune (NEXI) today is $ 0.000100, with return of -99.96% compared to the last year. The price of NexImmune (NEXI) started the year trading around $ 0.13 and today it is at $ 0.000100. Follow the real-time price chart, the historical price of NexImmune (NEXI) and international markets.

When does NexImmune (NEXI) pay dividends?

NexImmune (NEXI) did not distribute dividends in the last year.

Is NexImmune (NEXI) worth it?

Currently, NexImmune (NEXI) is priced at $ 0.000100, with a P/E of 0.00%, representing a deviation of -1,069% from its historical average P/E. In the last year, the stock showed a variation of -99.96 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -99.96%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy NexImmune (NEXI) stock?

Investing in stocks of NexImmune (NEXI) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of NexImmune (NEXI) yield today?

The yield of NexImmune (NEXI) was 0.00% in the last month, -99.96% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of NexImmune (NEXI) today, the total investment would be $ 0.01, based on the current price of $ 0.000100.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 0.000004
In 5 years: $ 0.01
In 10 years: $ 0.01

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

NEXI

NexImmune Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of NEXI

review the fundamentals of NexImmune shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY NexImmune

NexImmune Inc.

United States

14 years

2021

44

PROFIT X PRICE NEXI

Financial Results NEXI

NEXI cash flow

asset growth - NEXI

NEXI balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions